Britain approves Pfizer's antiviral Covid-19 pill | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 19, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 19, 2025
Britain approves Pfizer's antiviral Covid-19 pill

Europe

Reuters
01 January, 2022, 10:20 am
Last modified: 01 January, 2022, 10:25 am

Related News

  • Britain and India clinch major trade deal in 'new era' of Trump tariffs
  • Trump says US, Britain working on 'great' trade deal
  • Musk says 'Yes' to British MP's criticism of Bangla signboard at London station
  • Ancient DNA reveals women’s key role in Celtic social networks in Britain
  • Iran to hold nuclear talks with France, Britain, Germany on 13 January

Britain approves Pfizer's antiviral Covid-19 pill

Pfizer this month said Paxlovid showed near 90% efficacy in preventing hospitalisations and deaths in high-risk patients

Reuters
01 January, 2022, 10:20 am
Last modified: 01 January, 2022, 10:25 am
Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021.  Photo :Reuters
Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Photo :Reuters

Highlights:

* Second Covid-19 pill to be approved following rival Merck's

* MHRA recommends Pfizer's pill be used within 5 days of symptoms

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

* Effectiveness against Omicron being studied 


Britain has approved Pfizer's Covid-19 pill for adults who have mild to moderate infection and are at high risk of their illness worsening, its second easily administered antiviral against the coronavirus.

Britain is scrambling to build its defences amid a record hit a daily record of new Covid-19 cases on Thursday, government data showed surge in Covid-19 cases in the winter season as the Omicron variant of the virus spreads quickly.

Based on data, the pill, Paxlovid, is most effective when taken during the early stages of Covid-19, Britain's Medicines and Healthcare products Regulatory Agency (MHRA) said on Friday, recommending it be used within five days of the first symptoms.

Pfizer this month said Paxlovid showed near 90% efficacy in preventing hospitalisations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.

The MHRA said it is working with Pfizer, which makes one of the leading Covid-19 vaccines with German partner BioNTech , to track Paxlovid's effectiveness against Omicron.

"We now have a further antiviral medicine for the treatment of Covid-19 that can be taken by mouth rather than administered intravenously. This means it can be administered outside a hospital setting," MHRA chief June Raine said in a statement.

Paxlovid is made of two active substances which come as two separate pills taken twice a day together for five days. Britain has secured more than 2.75 million courses of the antiviral treatment.

The Pfizer tablets are part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses, which work by stopping the virus from replicating.

Rival Merck's Covid-19 pill was approved by Britain last month, but that drug only reduced hospitalisations and deaths in its clinical trial of high-risk patients by around 30%.

Coronavirus chronicle / Top News / World+Biz

Britain / Pfizer / antiviral Covid-19 pill

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Pvt sector's foreign loan rises by $454m on stable exchange rate, reserve in three months
    Pvt sector's foreign loan rises by $454m on stable exchange rate, reserve in three months
  • An anti-missile system operates as missiles are launched from Iran, as seen from Tel Aviv, Israel, 18 June 2025. Photo: Reuters
    Khamenei rejects Trump's demand for surrender, Trump says 'good luck'
  • Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?
    Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

MOST VIEWED

  • Infograph: TBS
    Govt to ease loan rules to help foreign firms expand in Bangladesh
  • Google Pay. Photo: Collected
    Google Pay coming to Bangladesh next week
  • Logo of Beximco Group. Photo: Collected
    Beximco defaults on €33m in Germany, Deshbandhu owes Czech bank €4m
  • Global map showing nuclear weapon inventories by country as of January 2025, including deployed, stored, and retired warheads. Source: SIPRI
    How Israel's secret nuclear arsenal comes under spotlight amid attacks on Iran
  • The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy
    Kallyanpur canal project shows how to combat plastic pollution in Dhaka
  • The India-Bangladesh integrated checkpost in Fulbari. Photo: Passang Yolmo via Telegraph India
    Import of boulders from Bhutan to Bangladesh stopped by Indian transporters in Fulbari

Related News

  • Britain and India clinch major trade deal in 'new era' of Trump tariffs
  • Trump says US, Britain working on 'great' trade deal
  • Musk says 'Yes' to British MP's criticism of Bangla signboard at London station
  • Ancient DNA reveals women’s key role in Celtic social networks in Britain
  • Iran to hold nuclear talks with France, Britain, Germany on 13 January

Features

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

9h | Panorama
The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

1d | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

2d | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

3d | Panorama

More Videos from TBS

What's going on in Netanyahu's head behind the regime change story?

What's going on in Netanyahu's head behind the regime change story?

9h | TBS World
The type of bomb the US could use if Trump attacks Iran

The type of bomb the US could use if Trump attacks Iran

9h | TBS World
Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

12h | TBS World
AI will replace jobs at tech giant: Amazon CEO

AI will replace jobs at tech giant: Amazon CEO

12h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net